Literature DB >> 27340897

Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.

Angela G E M De Boer1, Floor Bennebroek Evertsz', Pieter C Stokkers, Claudia L Bockting, Robert Sanderman, Daniel W Hommes, Mirjam A G Sprangers, Monique H W Frings-Dresen.   

Abstract

OBJECTIVES: To assess employment status, difficulties at work and sick leave in inflammatory bowel disease (IBD) patients and their relation with sociodemographic and clinical factors, quality of life (QoL), and anxiety and depression.
MATERIALS AND METHODS: IBD patients attending an IBD outpatients' clinic received self-report questionnaires on employment status, IBD-related difficulties at work and sick leave (Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness), sociodemographic factors, QoL (Inflammatory Bowel Disease Questionnaire and 12-item Short-form Health Survey) and anxiety and depression (Hospital Anxiety and Depression Scale). Disease activity was assessed by their gastroenterologist. Associations between paid employment and sick leave with sociodemographic and clinical factors, QoL and anxiety and depression were assessed by regression analyses.
RESULTS: In total, 202 IBD patients of working age, with a mean age of 41 years, participated; 63% had Crohn's disease and 37% had ulcerative colitis, and 57% were women and 19% had active disease. In all, 123 (61%) patients were in paid employment, of whom 31 (25%) were on sick leave, whereas 46 (23%) received a disability pension. Concentration problems (72%), low working pace (78%) and delayed work production (50%) were the most prevalent IBD-related work difficulties. IBD patients without paid employment were older and more often women, with active disease, lower QoL and higher anxiety and depression rates. Sick leave was associated with lower QoL and higher anxiety and depression rates.
CONCLUSION: More than half of IBD patients were in paid employment, whereas almost a quarter was receiving a disability pension. A large majority experienced work difficulties. Having no paid employment was associated with poorer QoL and more anxiety and depression symptomatology.

Entities:  

Mesh:

Year:  2016        PMID: 27340897     DOI: 10.1097/MEG.0000000000000685

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  24 in total

1.  The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.

Authors:  Renata de S B Fróes; Ana Teresa Pugas Carvalho; Antonio Jose de V Carneiro; Adriana Maria Hilu de Barros Moreira; Jessica P L Moreira; Ronir R Luiz; Heitor S de Souza
Journal:  Eur J Health Econ       Date:  2017-05-18

2.  Differing Relationship of Psycho-Social Variables with Active Ulcerative Colitis or Crohn's Disease.

Authors:  Orly Sarid; Vered Slonim-Nevo; Doron Schwartz; Michael Friger; Ruslan Sergienko; Avihu Pereg; Hillel Vardi; Elena Chernin; Terri Singer; Dan Greenberg; Shmuel Odes
Journal:  Int J Behav Med       Date:  2018-06

3.  Accommodations and Adaptations to Overcome Workplace Disability in Inflammatory Bowel Disease Patients: A Systematic Review.

Authors:  Emma Paulides; Richard B Gearry; Nanne K H de Boer; Chris J J Mulder; Charles N Bernstein; Andrew M McCombie
Journal:  Inflamm Intest Dis       Date:  2019-01-03

4.  Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany.

Authors:  Niels Teich; Michael Bläker; Frank Holtkamp-Endemann; Eric Jörgensen; Andreas Stallmach; Susanne Hohenberger
Journal:  Inflamm Intest Dis       Date:  2020-12-18

5.  Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease.

Authors:  Ryan C Ungaro; Liangyuan Hu; Jiayi Ji; Shikha Nayar; Subra Kugathasan; Lee A Denson; Jeffrey Hyams; Marla C Dubinsky; Bruce E Sands; Judy H Cho
Journal:  Aliment Pharmacol Ther       Date:  2020-11-01       Impact factor: 9.524

6.  Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.

Authors:  Lieke M Spekhorst; Bas Oldenburg; Ad A van Bodegraven; Dirk J de Jong; Floris Imhann; Andrea E van der Meulen-de Jong; Marieke J Pierik; Janneke C van der Woude; Gerard Dijkstra; Geert D'Haens; Mark Löwenberg; Rinse K Weersma; Eleonora A M Festen
Journal:  World J Gastroenterol       Date:  2017-12-14       Impact factor: 5.742

Review 7.  MMX® technology and its applications in gastrointestinal diseases.

Authors:  Silvia Nardelli; Laura Francesca Pisani; Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli
Journal:  Therap Adv Gastroenterol       Date:  2017-05-25       Impact factor: 4.409

8.  Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient's Characteristics.

Authors:  Konstantinos Argyriou; Andreas Kapsoritakis; Konstantinos Oikonomou; Anastassios Manolakis; Eirini Tsakiridou; Spyridon Potamianos
Journal:  Can J Gastroenterol Hepatol       Date:  2017-05-29

9.  The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.

Authors:  Murray W Enns; Charles N Bernstein; Kristine Kroeker; Lesley Graff; John R Walker; Lisa M Lix; Carol A Hitchon; Renée El-Gabalawy; John D Fisk; Ruth Ann Marrie
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

10.  Factors associated with health-related quality of life in patients with functional dyspepsia.

Authors:  Ibnu Fajariyadi Hantoro; Ari Fahrial Syam; Endang Mudjaddid; Siti Setiati; Murdani Abdullah
Journal:  Health Qual Life Outcomes       Date:  2018-05-02       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.